Perioperative antimicrobial prophylaxis in urology: A multi-center prospective study

Journal of Chemotherapy

Volumn 17, Issue 2, 2005, Pages 189-197

  Yamamoto, S ^a,b   Kanamaru, S ^a   Kunishima, Y ^a   Ichiyama, S ^a   Ogawa, O ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Perioperative antimicrobial prophylaxis; Remote infection; Surgical site infection; Urologic surgery

Indexed keywords

ANTIBIOTIC AGENT; CEPHEM; PENICILLIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM ISOLATE; BLEEDING; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; INFECTION RATE; INFECTION RISK; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL CONTAMINATION; MULTICENTER STUDY; OBESITY; OPERATION DURATION; PERIOPERATIVE PERIOD; PSEUDOMONAS AERUGINOSA; SURGICAL INFECTION; UROLOGIC SURGERY;

EID: 19544370510     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.2.189     Document Type: Article

References (20)

1. Wong ES. Surgical site infection. In Mayhall DG, ed. Hospital epidemiology and infection control. 2nd edn. Philadelphia: Lippincott, Williams & Wilkins, 1999:189-210.
2. Hollenbeak CS, Murphy D, Dunagan WC, Fraser VJ. Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol. 2002; 23:177-182.
3. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003; 9:196-203.
4. Salma TG. Current thoughts and controversies of antibiotic prophylaxis. Current Opinion Infect Dis 1992; 5:787-798.
5. Kriaras I, Michalopoulos A, Michalis A, et al: Prophylaxis in cardiac surgery. J Cardiovasc Surg (Torino) 1997; 38:605-610.
6. Saginur R, Croteau D, Bergeron MG. Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients. The ESPRIT Group. J Thorac Cardiovasc Surg 2000; 120:1120-1130.
7. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999; 20: 250-278.
8. Naber KG, Bergman B, Bishop MC, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 2001; 40:576-588.
9. Matsukawa M, Kunishima Y, Takahashi S, Takeyama K, Tsukamoto T. Staphylococcus aureus bacteriuria and surgical site infections by methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2001; 17:327-329.
10. Kanamaru S, Terai A, Ishitoya S, et al. Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urologic surgery: a preliminary study. Int J Urol 2004; 11:355-363.
11. Takeyama K, Shimizu T, Mutoh M, et al. Prophylactic antimicrobial agents in urologic laparoscopic surgery: 1-day versus 3-day treatments. J Infect Chemother 2004; 10:168-171.
12. Gasser TC, Wisard M, Frei R. Oral fleroxacin prophylaxis in transurethral surgery. J Urol 1996; 156:146-148.
13. Hall JC, Christiansen KJ, England P et al. Antibiotic prophylaxis for patients undergoing transurethral resection of the prostate. Urology 1996; 47:852-856.
14. Vuorisalo S, Haukipuro K, Pokela R, Syrjala H. Risk features for surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol 1998; 19:240-247.
15. Bratzler DW, Houck PM, for Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery, an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706-1715.
16. Morikane K, Konishi T, Nishioka M, Harihara Y, Kobayashi H. The present status of surgical site infections in Japan: from the report of the Japanese Nosocomial Infections Surveillance (JNIS) system. Jpn J Surg Infect 2003; 15:103-107.
17. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm 1999; 56:1839-1888.
18. Eachempati SR, Hydo L, Barie PS. Gender-based differences in outcome in patients with sepsis. Arch Surg 1999; 134:1342-1347.
19. Richards C, Edwards J, Culver D et al. Does using a laparoscopic approach to cholecystectomy decrease the risk of surgical site infection? Ann Surg 2003; 237:358-362.
20. Kingston RD, Walsh S, Robinson C, Jeacock J, Keeling F. Significant risk factors in elective colorectal surgery. Ann R Coll Surg Engl 1995; 77:369-371.